<DOC>
	<DOCNO>NCT01582646</DOCNO>
	<brief_summary>Neuropathic pain due lesion disease affect nervous system . Antidepressants ( ADs ) recommend first line treatment . In murine model , investigator evidence antidepressant antiallodynic action mediate β2-adrenergic receptor stimulation β-mimetics display effect . These data support idea β-mimetics could offer therapeutic alternative ADs neuropathic pain treatment . This study aim assess effect terbutaline neuropathic pain symptom .</brief_summary>
	<brief_title>Analgesic Effect Beta 2-mimetics Treatment Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>adult 18 75 year old neuropathic painful condition follow thoracotomy thoracoscopy least 3 month Exclusion criterion : cardiovascular risk unstable diabetes mellitus allergy terbutaline hypokaliemia without treatment untreated hypothyroidism HIV chemotherapyinduced neuropathy cancer treat chemo radiotherapy concomitant treatment βblockers , tricyclic ADs morphine concomitant pain severe neuropathic pain pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>